Literature DB >> 22140416

Opportunities and challenges in omics.

Mingming Ning1, Eng H Lo.   

Abstract

Entities:  

Year:  2010        PMID： 22140416      PMCID： PMC3226701          DOI： 10.1007/s12975-010-0048-y

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN： 1868-4483            Impact factor:   6.829


× No keyword cloud information.
  17 in total

1.  Lessons from controversy: ovarian cancer screening and serum proteomics.

Authors:  David F Ransohoff
Journal:  J Natl Cancer Inst       Date:  2005-02-16       Impact factor: 13.506

2.  Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer.

Authors:  Keith A Baggerly; Jeffrey S Morris; Sarah R Edmonson; Kevin R Coombes
Journal:  J Natl Cancer Inst       Date:  2005-02-16       Impact factor: 13.506

Review 3.  The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum.

Authors:  N Leigh Anderson
Journal:  Clin Chem       Date:  2009-11-02       Impact factor: 8.327

4.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

5.  Proteomic identification of novel plasma kallikrein substrates in the astrocyte secretome.

Authors:  Jia Liu; Ben-Bo Gao; Edward P Feener
Journal:  Transl Stroke Res       Date:  2010-08-28       Impact factor: 6.829

6.  Assessing the quality and reproducibility of a proteomic platform for clinical stroke biomarker discovery.

Authors:  Ediri Sideso; Michalis Papadakis; Cynthia Wright; Ashok Handa; Alastair Buchan; Benedikt Kessler; James Kennedy
Journal:  Transl Stroke Res       Date:  2010-08-14       Impact factor: 6.829

7.  Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings.

Authors:  Robert Brunkhorst; Waltraud Pfeilschifter; Christian Foerch
Journal:  Transl Stroke Res       Date:  2010-08-28       Impact factor: 6.829

8.  Detection of cancer-specific markers amid massive mass spectral data.

Authors:  Wei Zhu; Xuena Wang; Yeming Ma; Manlong Rao; James Glimm; John S Kovach
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

9.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Wing C Chan; Joseph M Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend B Smeland; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan L Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

10.  Selected reaction monitoring for quantitative proteomics: a tutorial.

Authors:  Vinzenz Lange; Paola Picotti; Bruno Domon; Ruedi Aebersold
Journal:  Mol Syst Biol       Date:  2008-10-14       Impact factor: 11.429
View more
  9 in total

Review 1.  Injury and repair in the neurovascular unit.

Authors:  Changhong Xing; Kazuhide Hayakawa; Josephine Lok; Ken Arai; Eng H Lo
Journal:  Neurol Res       Date:  2012-05       Impact factor: 2.448

Review 2.  Augmentation of crop productivity through interventions of omics technologies in India: challenges and opportunities.

Authors:  Rajesh Kumar Pathak; Mamta Baunthiyal; Dinesh Pandey; Anil Kumar
Journal:  3 Biotech       Date:  2018-10-19       Impact factor: 2.406

Review 3.  Application of proteomics to cerebrovascular disease.

Authors:  Mingming Ning; Mary Lopez; Jing Cao; Ferdinando S Buonanno; Eng H Lo
Journal:  Electrophoresis       Date:  2012-12       Impact factor: 3.535

4.  Resolving the negative data publication dilemma in translational stroke research.

Authors:  Paul A Lapchak; John H Zhang
Journal:  Transl Stroke Res       Date:  2011-03-01       Impact factor: 6.829

5.  From Analysis of Ischemic Mouse Brain Proteome to Identification of Human Serum Clusterin as a Potential Biomarker for Severity of Acute Ischemic Stroke.

Authors:  Hailong Song; Hui Zhou; Zhe Qu; Jie Hou; Weilong Chen; Weiwu Cai; Qiong Cheng; Dennis Y Chuang; Shanyan Chen; Shuwei Li; Jilong Li; Jianlin Cheng; C Michael Greenlief; Yuan Lu; Agnes Simonyi; Grace Y Sun; Chenghan Wu; Jiankun Cui; Zezong Gu
Journal:  Transl Stroke Res       Date:  2018-11-21       Impact factor: 6.829

Review 6.  Pharmaco-proteomics opportunities for individualizing neurovascular treatment.

Authors:  M M Ning; M Lopez; D Sarracino; J Cao; M Karchin; D McMullin; X Wang; F S Buonanno; E H Lo
Journal:  Neurol Res       Date:  2013-06       Impact factor: 2.448

Review 7.  Methodological issues in human studies of endocrine disrupting chemicals.

Authors:  Duk-Hee Lee; David R Jacobs
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

Review 8.  Praegnatio Perturbatio-Impact of Endocrine-Disrupting Chemicals.

Authors:  Vasantha Padmanabhan; Wenhui Song; Muraly Puttabyatappa
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

Review 9.  Omics strategies for revealing Yersinia pestis virulence.

Authors:  Ruifu Yang; Zongmin Du; Yanping Han; Lei Zhou; Yajun Song; Dongsheng Zhou; Yujun Cui
Journal:  Front Cell Infect Microbiol       Date:  2012-12-13       Impact factor: 5.293
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.